Market Review - The A-share market is expected to maintain resilience in the long term, but potential mid-term risks may increase due to factors such as valuation shifts, institutional settlement cycles, and high market sentiment indices [2] - In November, the market experienced a mid-term adjustment after reaching new highs in the first half of the month, with major indices declining in the latter half [2][10] Economic Environment - In October, several economic indicators, including fixed asset investment and retail sales, showed slower growth than expected, with CPI rising and PPI continuing to decline [3][29] - The manufacturing PMI remained below the prosperity range, indicating that the economy requires sustained efforts for improvement [3] Policy Environment - The government is focusing on boosting consumption and effective investment, with plans to develop three trillion-level consumption sectors by 2027 [4] - The overall stability of major country relations is maintained, with a tactical easing in China-US economic relations, although geopolitical tensions persist [4] Investment Strategy - The market is currently in a phase of valuation consolidation, with a dynamic balance between profit-taking and short-selling sentiment [7] - Investors are advised to focus on fundamental research and gradually position themselves for the upcoming year, maintaining a "barbell" strategy that emphasizes dividend assets and technological innovation [7] Industry Performance - As of November 28, 90.3% of the 28 Shenwan first-level industries have seen year-to-date increases, with non-ferrous metals and communications industries rising over 50% [15] - In November, the comprehensive and banking sectors outperformed, while sectors like computers and automobiles faced declines [15][19] Fund Flow - As of November 28, southbound funds recorded a cumulative net inflow of 50,797 million HKD, with a monthly net inflow of 1,218.9 million HKD [25] - Margin financing balances have decreased, indicating a potential cooling in market sentiment after reaching historical highs [27] Economic Indicators - The GDP growth forecast for Q4 is 4.5%, with various economic indicators showing signs of slowing down, including fixed asset investment and manufacturing PMI [30][29] - The CPI rose by 0.2% in October, while PPI continued to decline, reflecting ongoing challenges in the industrial sector [33][36]

Core Viewpoint - The most unfavorable phase for institutions is about to pass, with a shift in market dynamics expected as December approaches, leading to a stronger correlation between market movements and fundamentals [1] Group 1: Market Timing and Trends - The period from December to January is identified as an excellent time for positioning in the market, particularly for sectors with favorable annual report forecasts [1] - The "spring market excitement" window, lasting approximately 20 trading days, is anticipated between the Spring Festival and the Two Sessions, characterized by a shift from low to high win rates and a transition from large-cap to small-cap styles [1] Group 2: Market Adjustments - Many sectors have already experienced an average adjustment of around 20%, aligning with historical averages for mainline varieties, suggesting that December is a suitable time to start monitoring these sectors [1]

Investment Rating - The report maintains a positive outlook on the non-bank financial sector, particularly highlighting the potential benefits for brokerage firms and insurance companies in the upcoming year [3][4]. Core Insights - The report emphasizes the expected inflow of passive funds into newly included stocks in major indices, which could enhance liquidity and market performance for these stocks [4]. - It identifies key trends for 2026, including a shift in insurance companies' focus towards asset-liability matching and the stabilization of core business indicators due to new regulatory standards [4]. - The report recommends specific brokerage firms such as Dongfang Securities, GF Securities, Huatai Securities, and China Galaxy, as well as insurance companies like China Life and Ping An, based on their competitive positioning and growth potential [4]. Summary by Sections Market Performance - The Shanghai Composite Index closed at 4,526.66 with a weekly increase of 1.64%, while the non-bank index rose to 1,932.15, reflecting a 0.68% increase [7]. - The brokerage sector index reported a 0.74% increase, and the insurance sector index saw a 0.20% rise [7]. Brokerage Sector Insights - Notable stocks in the brokerage sector included Guosheng Securities and Xinyi Securities, which saw increases of 3.68% and 3.36%, respectively [9]. - The average daily trading volume for the Shanghai and Shenzhen markets was 17,370.85 billion, a decrease of 6.87% week-on-week, but a year-to-date increase of 61.11% [20]. Insurance Sector Insights - The insurance sector is expected to experience a systematic revaluation in 2026, driven by long-term interest rate increases and continued investment from insurance funds into the stock market [4]. - The report highlights the performance of major insurance companies, with A-shares like China Life and Ping An showing modest increases [9]. Key Data Points - As of November 28, 2025, the average daily trading volume was 19,147.38 billion, and the margin trading balance was 24,720.45 billion, reflecting a year-on-year increase of 32.6% [51][20]. - The report notes that the total market value of private equity funds reached 22.05 trillion, marking a historical high [21].

Core Insights - China has completed the first phase of 6G technology trials, establishing over 300 key technology reserves, with a focus on developing standards and industrial research during the 14th Five-Year Plan period, aiming for commercial applications around 2030 [1][2][3] Group 1: Technological Developments - The first phase of 6G trials has been completed, focusing on key technology directions [2][3] - A demonstration system for 6G has been developed, showcasing real-time wireless control with high demands for latency and stability [1] - The goal for 6G is to achieve air interface transmission latency as low as 100 microseconds and reliability of 99.99999% [1][2] Group 2: Industrial Applications - 6G is expected to replace critical control buses in industrial settings, laying the foundation for fully automated factories [2][3] - By 2030, 6G is projected to provide customized, immersive, and intelligent application services across various life scenarios [3] Group 3: Market Potential - The global 6G technology market is projected to grow from $1.66 billion in 2024 to $14.94 billion by 2030, with a compound annual growth rate of 43.98% [6] - By 2040, the number of global smart terminal connections is expected to exceed 12.16 billion, significantly increasing from current 5G levels [7] Group 4: Policy and Support - The Chinese government has initiated policies to support the integration of AI with 6G and other advanced technologies, promoting innovation and application in various sectors [4] - Local governments in Beijing and Shanghai are encouraging the development and application of 5G/6G technologies in industrial settings [4]

Core Insights - China has completed the first phase of 6G technology trials, establishing over 300 key technology reserves [1][2] - The future of 6G technology is expected to empower various industries, particularly in creating smart factories with precise wireless control [1][2] - The goal for 6G is to achieve ultra-low latency and high reliability, enabling seamless collaboration among industrial devices [2][3] Industry Development - During the 14th Five-Year Plan period, China will focus on 6G standard development and industrial research, with commercial applications expected to start around 2030 [2][3] - By 2035, 6G is projected to achieve large-scale commercial deployment, potentially creating a trillion-yuan industry [3] - The 6G technology trials are divided into three phases: key technology trials, technical solution trials, and system networking trials [3] Policy Support - The Chinese government has initiated policies to support the integration of AI with 6G and other advanced technologies [4] - Local governments, such as in Beijing and Shanghai, are promoting the application of 5G/6G technologies and encouraging innovation in related fields [4][5] Market Potential - By mid-2025, China is expected to hold approximately 40.3% of global 6G patent applications, leading the world [5] - The global 6G technology market is projected to grow from $1.66 billion in 2024 to $14.94 billion by 2030, with a compound annual growth rate of 43.98% [5] - By 2040, the number of global smart terminal connections is expected to exceed 12.16 billion, significantly increasing from current 5G levels [6] Investment Opportunities - Investment in 6G is anticipated to focus on expanding terminal connections, upgrading functionalities, and enhancing commercial value [6] - Companies involved in traditional communication equipment, as well as those in emerging applications like vehicle networking and IoT modules, are expected to benefit from 6G developments [6]

Market Performance - The Sci-Tech 50 Index increased by 3.21% and the ChiNext Index rose by 4.54% over the last five trading days, while the large-cap value index decreased by 0.21% [1] - The large-cap growth index gained 2.63%, the Shanghai 50 Index rose by 0.47%, and the small-cap index represented by the CSI 2000 increased by 4.50% [1] - The communication and electronics sectors performed well, while the oil, petrochemical, and banking sectors lagged behind [1] Valuation Levels - As of November 28, 2025, the static PE of the CSI All Share Index is at a percentile of 79%, with the Shanghai 50 and CSI 300 at 75% and 71% respectively [1] - The ChiNext Index is close to the 48th percentile, while the CSI 500 and CSI 1000 are at 60% and 57% respectively, indicating that the ChiNext Index's valuation is relatively at the historical median level [1] ETF and Fund Flows - In the last five trading days, ETF inflows amounted to 8.2 billion yuan, while margin trading decreased by approximately 19.1 billion yuan [2] - The average daily trading volume across both markets was 172.38 billion yuan [2] Thematic Investment Focus - The latest thematic investment focus includes traditional Chinese medicine, banking, and high-dividend stocks, specifically targeting indices such as the CSI Traditional Chinese Medicine Index, CSI Banking Index, and the Shanghai State-Owned Enterprises Dividend Index [2][3] Long-term Market Sentiment - The report includes observations on the proportion of stocks above the 200-day moving average, indicating long-term market sentiment [13] Risk Preference Tracking - The report tracks the risk preference between equity and bond assets, providing insights into market behavior [14] Financing Balance - The report discusses the financing balance, which is crucial for understanding market liquidity and investor sentiment [16] Individual Stock Performance - A statistical distribution of individual stock performance year-to-date based on return intervals is provided, highlighting the performance landscape [18] Oversold Indices - The report notes instances of oversold conditions in certain indices, which may present potential buying opportunities [20]

Investment Rating - The industry investment rating is optimistic (maintained) [1] Core Views - The insurance sector is preparing actively for the 2026 "opening red" period, with a focus on dividend insurance products, which are expected to outperform traditional insurance due to higher yield rates [6] - The brokerage sector continues to show high profitability, with wealth management, investment banking, and overseas business expected to drive earnings improvement [5][7] - The long-term interest rates are stabilizing at the bottom, which is expected to support the asset side logic and improve the liability cost for insurance companies [6] Summary by Sections Insurance Sector - The insurance companies are gearing up for the 2026 "opening red" with dividend insurance becoming the main product, offering a yield rate significantly higher than traditional insurance [6] - The market share of listed insurance companies is expected to increase due to the expansion of bank insurance channels and the release of "storage demand" [6] - The overall outlook for the liability side is optimistic, with potential improvements in the value rate of dividend insurance supported by rate adjustments and structural optimization [6] Brokerage Sector - The average daily trading volume of stock funds from January to November increased by 77.1% year-on-year, indicating strong market activity [7] - The China Securities Regulatory Commission has proposed to include commercial real estate in the public REITs pilot program, which is expected to enhance the market for REITs [7] - Major brokerage firms are expected to see significant ROE expansion under the current growth-oriented strategy, with low valuations presenting strategic allocation opportunities [7] Recommended Stocks - Recommended stocks include China Pacific Insurance, Ping An Insurance, China Life Insurance H, Huatai Securities, Guotai Junan, and others [8]

2025年即将收官，市场在结构性行情中寻找新的方向。新质生产力主线持续凸显，硬科技领域展现出蓬 勃生机，资本市场正以更加理性的目光审视中国资产的内在价值。 在这个关键节点，"共识"的价值愈发凸显。如何理解当前市场的估值逻辑？如何把握新一轮资产重估中 的投资机遇？这些问题亟待深入探讨。 2025年12月6日下午，广州南方财经大厦将迎来一场思想盛宴——证券业年会暨2025年21世纪金牌分析 师颁奖典礼。 21世纪经济报道 记者 崔文静 时序更迭，中国资本市场正迎来新一轮价值重估的重要窗口。 研究所长层面，长江证券邬博华、浙商证券邱冠华、华创证券董广阳等负责人将齐聚一堂。他们带领的 研究团队，每天都在市场最前沿进行深入分析，他们的集体智慧值得期待。 本次年会汇聚十位知名首席经济学家、多家券商掌门人及研究所所长，围绕"中国资产重估——A股趋 势"展开深度对话。这是一次市场声音的集中呈现，也是一次专业智慧的集体碰撞。 同时，第五届21世纪金牌分析师评选榜单也将揭晓。这份经过严格评选产生的榜单，将为市场提供专业 的参考坐标。 本次证券业年会的一大亮点，是众多首席经济学家的集体亮相。他们将围绕"中国资产重估——A股趋 势" ...

Group 1 - The innovation drug sector is experiencing a volatile trend in the fourth quarter, with positive signals in the funding landscape as significant capital flows into innovation drug-themed ETFs, totaling over 19 billion yuan in net subscriptions as of November 28 [1] - Despite a strong performance earlier in the year, the innovation drug sector faced a correction in the fourth quarter, with an average decline of approximately 10% in themed funds as of November 28, yet funds continued to increase their positions, leading to substantial growth in several innovation drug-themed ETFs [3] - The growth of specific ETFs is notable, with the scale of the GF Hong Kong Innovation Drug ETF increasing from 7.875 billion yuan at the end of last year to 25.276 billion yuan, and the Huatai-PineBridge Hong Kong Innovation Drug ETF rising from less than 700 million yuan to over 24 billion yuan [3] Group 2 - Industry experts believe that the long-term investment value of the innovation drug sector is becoming more apparent, although the phase of broad market gains may be over, necessitating a focus on stock selection for future investments [4] - The report from Industrial Securities indicates that the trend of "innovation + internationalization" in the innovation drug industry remains unchanged, with increased elasticity in the sector following the recent adjustments, and a positive outlook on the fundamentals of the innovation drug industry chain [4]

Core Viewpoint - The article highlights the complete withdrawal of several brokerage asset management subsidiaries from the public fund license application process, indicating a significant shift in the industry as the deadline for compliance with new regulations approaches [2][3][6]. Group 1: License Application Status - As of November 28, no brokerage asset management companies are currently in line to apply for public fund licenses, marking a total withdrawal from the application process [3]. - Initially, four companies, including Guotai Junan Asset Management, were in the queue for public fund licenses, but all have now withdrawn their applications [2][6]. - The withdrawal of applications is seen as a response to regulatory signals indicating that no new public fund licenses would be granted to brokerage asset management firms [6]. Group 2: Regulatory Background - The asset management industry is undergoing a transformation due to the 2018 regulations requiring brokerage firms to convert their "public collective" products to comply with public fund standards by the end of 2025 [8]. - The transition has led to various strategies, including changing management to public fund institutions, converting products to private funds, or liquidation [9]. Group 3: Industry Trends - The article notes that only 14 out of 30 brokerage asset management subsidiaries have successfully obtained public fund licenses, with the majority of applications failing to progress [7]. - The trend of transferring management of collective products to affiliated public fund companies is becoming common among brokerage firms, as seen with companies like CITIC Asset Management and GF Asset Management [10]. - Some firms are also exploring partnerships with unrelated fund companies for managing their products, indicating a diversification of management strategies [10][11].